Asher sold 3.8 million shares today. At this share price, the $31,000 note converts into 76.3 million shares.

Not only is Moro scamming the proxy votes, he is pocketing the Canadian SR&ED money instead of reducing his charges by his personally owned company, Pacific BioSciences.

Moro has put about $1.5 million in his pocket from Rebates by the SR&ED program.

Moro is totally silent about pocketing all this money.

It has been 26 days since Moro filed the 8K announcing a reverse split. What happened? Has FINRA not approved it?

Since Moro sold his 80 million shares back to BioCurex, there are 308,655,000 outstanding shares.

What a scam. Back in 2009, Moro exercised a TON of options and voted them in the shareholder proxy. He then UNEXERCISED them.

In July 2012, Moro bought 80 million shares with debt to Pacific BioSciences. He voted on the proxy. He then sold the shares back to BioCurex for debt.

This company is a TOTAL SCAM.

Moro tells more lies.

From the 8K filed on Oct 12, 2012:

" The reverse split will become effective on the OTC Bulletin Board when FINRA has approved the Company's documentation pertaining to the stock split."

BioCurex is on the PINK SHEETS.


"BioCurex Inc. Deleted From OTCBB

Jul 23 12

BioCurex Inc.’s common stock has been deleted from OTC Bulletin Board (OTCBB) effective July 23, 2012 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11."


http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=BOCX

Unless MacLellan pumps the stock again, the sales have dried up. IMO, Mac wont pump the stock any more. I think he is pleased to get away without being personally sued by the lenders.

Those now holding shares? I think you are stuck with them.

There is a reason why this stock sells for $.0001 or lower. No good news is anticipated by anyone who has done any reasonable DD on the stock.

Shawn stated: "Cheapest FDA approved stock is above $2.00 range, Go $RXPC!!"

No Shawn, the cheapest FDA approved stock is $.0001 and is Radient. Their Onko Sure test was cleared by the FDA in 2008 but has never had any significant sales nor appeal to the medical community.

Very interesting. All of the trades below $.0001 were "unsettled" trades. Are the lenders selling below .0001? I think so.

Bulldog, qotemedia.com will give you accurate time and sales but is 15 minute delayed.

Top Penny, by SEC rules, $.0001 is the lowest price a stock can be "quoted" but a market maker can sell the stock for a price less than the quote and since you cannot quote a stock to the 5th decimal, it shows up as a sale at zero.

Indeed, the last 4 trades of 3.8 million shares all sold for less than $.0001.


$0.0000

500,000

OTO

09:34:55




$0.0000

834,999

OTO

09:34:55




$0.0000

500,000

OTO

09:34:55




$0.0000

2,006,005

OTO

09:34:55




$0.0001

1,000,000

OTO

09:34:48




$0.0001

1,000,000

OTO

09:34:48

Top Penny, the article you quote suggests that Onko Sure combined with AFP may be useful in monitoring HCC. The real problem with HCC is finding it in the first place. Once it is found and treated, it only has a 10% survival rate and according to the article, an Onko Sure test at that point will just tell you how long you would have to live.

Also, take note that you cannot screen a general population with any test that has a specificity of 77%. The number of false positives would be MASSIVE.

Top Penny, the abstract you quote in your post was written by employees of Radient. It certainly was not an independent study. Also note the comment on sensitivity. Yes, it would be increased but there is TOTAL silence on what the specificity was in the study. The reason? There would have been a HUGE number of false positives making a combined test worthless.

There is another study that was total independent done by British researchers whose conclusion was that Onko Sure was not a useful test even when combined with other markers.

You should do some research on the history of Radient. The hay day was in 2007 and 2008 when they were in the process of becoming a Chinese pharmaceutical company via Jade. The CEO even moved Onko Sure to a different division and attempted to sell it off. NO BUYERS. Now, if Onko Sure actually had value, would the company try to sell it off?

When Jade blew up in their face from MacLellan's handling of their assets, Radient had nothing left but Onko Sure. So what does the CEO do? Does he just close the doors? No, he hypes the heck out of Onko Sure. Changes the name of the product and the name of the company hoping everyone one would forget the failures of DR70, the old name. Lots of people fell for the hype and that's where you are today.

Why change the name? Do you remember Value Jet who put a plane in the swamps off Miami because they were carrying illegal cargo? Ask anyone who remembers if they would still fly Value Jet. Most would probably say, "NO WAY".

Well think again. The management of Value Jet bought Air Tran. Changed their name, repainted the Value Jet aircraft to the Air Tran colors and they are off and running again with the same management who sanctioned carrying the illegal cargo just to save a few bucks. Ask those flying Air Tran if they would ever fly a carrier like Value Jet? Ignorance is bliss and that is why MacLellan changed the name to Onko Sure.

Top Penny stated: "What I have found and read about Onko-Sure, I like a lot."

Please tell us what you like about Onko Sure.

Here are some facts you may not be fully aware of.

1. The product has been around for a LONG, LONG time and with very little interest from the medical community.

2. Radient paid the bills to take the test all the way through FDA clearance to monitor colon cancer and year after FDA clearance in 2008, they could not find anyone to license the test. They finally just began giving away distributorships.

3. If you look at the FDA application, CEA actually performs better in monitoring colon cancer than Onko Sure in the vast majority of cases.

4. As a screening tool for cancer, it is worthless because it has WAY too many false positives. During a conference call over a year ago, I stated some facts about the fales positive rate being really high and MacLellan agreed with my figures and stated that is why they were not advocating it as a general screen. At the time, MacLellan was attempting to hawk the product to the Indian government as a screening tool.

5. Most of the small number of kits are being sold are to Asian countries and very few in other places.

Now, again, please tell us what you like about Onko Sure.

BioCurex Inc. Deleted From OTCBB

Jul 23 12

BioCurex Inc.’s common stock has been deleted from OTC Bulletin Board (OTCBB) effective July 23, 2012 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.

At the end of November/first of December, there will probably be more employee selling and another plunge in share price.

Charlie, Radient has been on the DTCC chill list for a long time. Anyone buying shares should have known that.

It would appear that investors have finally figured out that Radient is toast and is not ever going to survive or increase in share price.

Radient is running out of antibody to manfacture kits so even the meager sales are going to cease.

IMO, the next step is up to the lenders. Will they go to court and sue for assets?

Today is the 10th day following the notice for a reverse split.

FINRA will approve a reverse split within 10 days UNLESS there are further investigations into why the reverse split should be approved.

My ticker shows two trades today at $.0000.

The trades that show as .0000 are trades that occur at less than .0001. The actual trade price cannot be quoted below the .0001.

Charlie, the lenders are indeed selling shares at .0001. Read the amended agreements.

There is NO sales force. All workers have been laid off but they are using two former employees as consultants to assemble kits using the remaining antibody they have left to fill what orders come in.

Nothing good is going to happen with Radient.

Charlie, 1.5 billion shares sold in 10 days between .02 and .0002. Do the math again and look at the historical prices. The volume increased greatly as the share price dropped close to .0002,

No, the lenders probably did not intend to take the price to .0001. It is just the way the trading went and it only takes one seller to cause the plunge.

When the last agreement was made, the 7 lenders got the right for unlimited sales and the law firm got $300,000 in notes to also convert at full ratchet price. IMO, the law firm quickly dumped their shares and within a few days and took the price to rock bottom. They had a limited amount to sell and quickly got their money.

So, if you want to blame someone, think lawyers.

These are the hedge funds involved.

Iroquois Master Fund Ltd.
Cranshire Capital, L.P.
Freestone Advantage Partners, LP
Bristol Investment Fund, Ltd.
Kingsbrook Opportunities Master Fund LP
Alpha Capital Anstalt
Whalehaven Capital Fund, Ltd.

The lawyers:

" HTW has agreed to accept from the Company, as an account stated, a $300,000 unsecured convertible 4% Company note which shall (i) accrue interest at the annual rate of 4% per annum, (ii) be convertible into Company Common Stock at a fixed conversion price of $0.01 per share, (iii) be subject to prepayment at the option of the Company, (iv) contain full ratchet and other customary anti-dilution protection"

Full ratchet means a price equal to the lowest price any notes are converted by Radient into shares.

Within 10 days of signing the above agreement with the lenders and law firm, over 1.5 billion shares traded and the share price went from .02 to .0002. That was just too many shares to sell in a short time frame and someone just outstripped the demand. The share price hit .0001 a couple days later.

Penny, with the low volume, it will take a LONG time to max out the authorized shares.

The problem with the lender is the number of them selling. There are 5 from the 2011 loan and 2 from a 2009 loan. The 5 might come to some arrangement to limit sales but the other two have been known for dumping shares so I doubt it would be likely for them to agree on something, especially sale of shares.

Legs, it looks like not too many people are interested in buying this stock any more.

BTW, I sent a note to the SEC that the lenders were selling shares without current SEC filings. The lenders are using rule 144 to register their shares and that is illegal without current SEC filings.

If more people sent notices to the SEC, they might shut down the lenders selling and the share price might go up. Do what you like. I have no pony in this deal. I just like for trading to be legal.

It would appear that Asher is selling a lot of shares today taking advantage of the bid at .0012.

IMO, FINRA is not going to approve a 1 for 150 reverse split that eliminates some shareholders.

AsAer sold on the first trade of the day for 449,100 shares. Expect more selling over the next three or so weeks as he converts the third loan.

If the reverse split is approved by FINRA, the outstanding shares would drop from 450 million to 3 million.

FINRA will take about a month to make a decision on the split so during that time, Asher will convert the last note beginning on Monday. A substantial number of shares will be sold prior to any approval. Also there may be another round of employee selling of shares so the share price may be quite low.

Depending on the share price at the time of the split, it should begin trading the following morning at about 10 cents.

The reverse split could take about a month to get past FINRA.

Charlie, you can believe me or not but the lenders are selling shares and then sending notice to Radient to convert a portion of the not for that number of shares. These funds NEVER convert and hold shares. That's not the way they work. Most of the hedge funds have automated trading programs so there is really no one actively trading. They just set the program and it does what it does.

The lender know they are never going to get the full 18 million back and with interest and penalties, that amount will even get larger. What ever money they make by selling shares is just basically free money for them.

Charlie, in the last round of financing in Feb 2011, Radient netted about 6 million from a loan. The defaulted on that loan and penalties have been severe.

Also, they were sued by two hedge funds and gave them convertible notes for mega millions.

They have repaid a lot of the loan but the penalties and interest from the multiple defaults have raised the owed balance to over $18 million according to the last SEC filing Radient made.

Charlie, the reverse split was done because the lenders wanted to sell more shares.

I and others were warning investors about this stock 3 years ago after Jade bailed. At that point, there was nothing left but Onko Sure and it will never have significant revenue.

Back in 2008 when Jade was making money for Radient, the old CEO placed DR70 into another division and announced that he intended to sell it off. Apparantly, no one was interested.

MacLellan ousted the CEO, took over the company and promptly hacked off Jade and they refused to send any more of their profits to Radient. MacLellan then announced they were going to concentrate on DR70, changed the name of the product to Onko Sure and the name of the company to Radient pharmaceuticals. At that point, the lies began and the hype flowed like water. Debt piled up, lies were exposed and that brings it up to date with the company broke and owing $18 million to the lenders.

Charalie, the India deal was mostly all lies and they were exposed by the street.com.

I know you would like something good to happen but it is just not going to happen here.

The real problem with Radient is that Jade blew up in their face and all that was left for Radient was Onko Sure, a test that is never going to have much revenue at all. There waS just nothing here but a lot of hot air from the CEO. He got more and more bold with his lies at time past and the last big lies were to the lenders. These are hedge funds and they break legs, well financially anyway.

This is from an 8K noting the fact that shares cannot be legally sold by the lenders if the SEC filings are not current.

Both of the 10Q's for 2012 have NOT been filed. The current conversion and sale of shares by the lenders is illegal.

"Until the 10-K, and 10-Q, are filed with the SEC, shareholders will not be able to sell their shares in our Company pursuant to Rule 144 under the Securities Act of 1933, as amended."

Charlie, the lenders have most likely determined that very few assets remain at Radient. Their most profitable course of action remains to be converting notes and selling whatever shares they can. After that, they can still sue for any remaing assets.

The lenders are definitely in violation of rule 144 by selling shares of a company not current in financial filings.

"What Are the Conditions of Rule 144?
If you want to sell your restricted or control securities to the public, you can follow the applicable conditions set forth in Rule 144. The rule is not the exclusive means for selling restricted or control securities, but provides a "safe harbor" exemption to sellers.

Adequate Current Information. There must be adequate current information about the issuer of the securities before the sale can be made. This generally means that the issuer has complied with the periodic reporting requirements of the Exchange Act."

http://www.sec.gov/investor/pubs/rule144.htm

If anyone wants to stop this illegal action, go to the SEC website and fill out the notice of violation.

https://denebleo.sec.gov/TCRExternal/questionaire.xhtml

A filing such as an S-1 is required if new debt is issued and the lender wants to sell prior to the normal wait of 6 months.

The current debt is over 6 months and the lenders are selling without a registration filing via rule 144. To be legal, Radient would need to be up to date with current SEC financial filings but it would appear that is currently being ignored by Radient and the lenders.

If enough people complained to the SEC about the lenders selling under rule 144 without current financial filings, the SEC might step in and stop the lenders selling but at the same time, they would probably shut Radient down and cease trading.

Charlie, the lenders have notes to convert. The mechanics of how the sell is as follows.

The sell shares via a broker who will wait for the shares to be received a few days later. The lender then gives notice to Radient to convert some of their shares and Radient then gives notice to the trasfer agent located in Denver to send new shares to the selling broker. When this evolution is completed, the unsettled trade with the broker is then resolved.

The lenders converte notes into shares at a 20% discount to current market which would be .00008.

If and when the total outstanding shares hits the 5 billion mark, that's the end of lender sales. At that point, the lenders may decide to sue for assets.

And it goes right back to 9 bid and 15 million on the ask. Again, those .0001's for sale are not going away.

Ite quote is back to the standard of no bid and 15 million on the ask. Anyone who thinks the lenders are going to stop selling at .0001 is just being foolish.